Corresponding Author: J. John Mann, MD,
Department of Neuroscience, New York State Psychiatric Institute, 1051 Riverside
Dr, Box 42, New York, NY 10032 (jjm@columbia.edu).
Author Contributions: Dr Mann had full access
to all of the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis.
Study concept and design: Mann, Apter, Beautrais,
Haas, Hegerl, Lonnqvist, Malone, Mehlum, Schmidtke, Shaffer, Varnik, Wasserman,
Yip, Hendin.
Acquisition of data: Mann, Apter, Bertolote,
Hegerl, Lonnqvist, Malone, Marusic, Mehlum, Phillips, Silverman, Takahashi,
Hendin.
Analysis and interpretation of data: Mann,
Bertolote, Beautrais, Currier, Haas, Hegerl, Malone, Marusic, Mehlum, Patton,
Rutz, Rihmer, Silverman, Hendin.
Drafting of the manuscript: Mann, Apter, Beautrais,
Currier, Haas, Hegerl, Schmidtke, Shaffer.
Critical revision of the manuscript for important
intellectual content: Mann, Apter, Bertolote, Beautrais, Haas, Hegerl,
Lonnqvist, Malone, Marusic, Mehlum, Patton, Phillips, Rutz, Rihmer, Schmidtke,
Shaffer, Silverman, Takahashi, Varnik, Wasserman, Yip, Hendin.
Statistical analysis: Mann, Marusic.
Obtained funding: Malone, Hendin.
Administrative, technical, or material support:
Beautrais, Currier, Haas, Hegerl, Lonnqvist, Patton, Schmidtke, Silverman,
Hendin.
Study supervision: Mann, Rutz, Rihmer.
Financial Disclosures: Dr Mann received a grant
from GlaxoSmithKline to do a positron-emission tomography study of Alzheimer
disease; otherwise, no financial disclosures were reported.
Funding/Support: Funding for the International
Strategies Workshop was provided by an unrestricted educational grant from
Pfizer Inc.
Role of the Sponsor: Pfizer had no role in
the design and conduct of the study; collection, management, analysis, and
interpretation of the data; and preparation, review, or approval of the manuscript.